Welcome to LookChem.com Sign In|Join Free

CAS

  • or

57704-54-8

Post Buying Request

57704-54-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

57704-54-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 57704-54-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,7,0 and 4 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 57704-54:
(7*5)+(6*7)+(5*7)+(4*0)+(3*4)+(2*5)+(1*4)=138
138 % 10 = 8
So 57704-54-8 is a valid CAS Registry Number.

57704-54-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-hydroxy-benzoic acid tert-butyl ester

1.2 Other means of identification

Product number -
Other names tert-butyl 2-hydroxybenzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57704-54-8 SDS

57704-54-8Relevant articles and documents

MACROCYCLIC DIAMINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS

-

Paragraph 0486; 0539, (2021/10/15)

The present invention relates to macrocyclic diamine derivatives of formula II, including pharmaceutically acceptable salts and solvates thereof. Compounds of the invention are inhibitors of ENT family transporter, especially of ENT1, and are useful as therapeutic compounds for the treatment of cancers. The invention also relates to the combined use of the macrocyclic diamine derivatives with an adenosine receptor antagonist, for the treatment of cancers.

4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives

-

Page/Page column 29, (2010/11/26)

The present invention relates to compounds of the formula medicaments containing them and the use of these compounds as pharmaceutically active agents. The compounds exhibit activity as Raf kinase inhibitors and therefore may be useful for the treatment of diseases mediated by said kinases, especially as anticancer agents.

Chiral carboxylic acid ligands derived from camphoric acid

Moloney, Mark G.,Paul, Diana R.,Thompson, Russell M.,Wright, Emma

, p. 2551 - 2562 (2007/10/03)

Versatile and convenient preparations of chiral carboxylic acid ligands, derived from camphoric acid, are described, either by esterification of camphoric dichloride or by a regioselective opening of the corresponding anhydride by a variety of alcohols or diols.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57704-54-8